Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs UBS Group AG Registered Ordinary Shares (UBS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs UBS Group AG Registered Ordinary Shares — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B), while UBS Group AG Registered Ordinary Shares trades at $47.37 (market cap $144.63B). The key difference: UBS Group AG Registered Ordinary Shares is far larger — about 63.4× SELLAS Life Sciences Group Inc. Common Stock's market cap, and UBS Group AG Registered Ordinary Shares pays a 2.32% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| SLS | UBS | |
|---|---|---|
Market Cap | $2.28B | $144.63B |
Volume | 3,128,960 | 1,746,723 |
Sector | Health | Financials |
52-Week High | $15.46 | $55.72 |
52-Week Low | $1.39 | $36.41 |
Enterprise Value | $2.15B | $311.50B |
Typical Hold Time | — | 0 Days |
Dividend Yield | — | 2.32% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About UBS Group AG Registered Ordinary Shares
UBS is a global financial services company focused on wealth management, investment banking, and asset management. It serves private, corporate, and institutional clients.
Read more on UBS →
